Clinical Trial: A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis

U.S., Dec. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07260669) titled 'A Phase 2 Trial to Investigate Efficacy and Safety of Vipoglanstat in Women With Endometriosis' on Sept. 29.

Brief Summary: The main objective of the trial is to evaluate the efficacy of vipoglanstat on endometriosis-related non-menstrual pelvic pain (NMPP).

Study Start Date: Oct. 15

Study Type: INTERVENTIONAL

Condition: Endometriosis

Intervention: DRUG: Vipoglanstat

Participants will receive vipoglanstat capsules orally for approximately 4 menstrual cycles during the treatment period.

DRUG: Placebo

Participants will receive matching placebo capsules orally for approximately 4 menstrual cycles during the treatment period.

R...